Phase 1 study of KT-413, a targeted protein degrader, in adult patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Background: The signal transducer and activator of transcription 3 ...
Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: results from the VISION trial sub-study. This is an ASCO Meeting Abstract from the 2022 ASCO ...
The mathematical principles of Ptolemy’s Planisphaerium enabled the projection of the three-dimensional universe onto a flat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results